Novo Nordisk AS 2025 AR2
The report highlights Novo Nordisk's performance in 2025, a year of profound transformation marked by a company-wide restructuring that reduced the global workforce by approximately 9,000 positions. Despite these challenges, the company reached 45.6 million patients living with diabetes and obesity, representing a 1% increase from 2024. Financially, sales grew by 6.4% to DKK 309,064 million, driven by a 31% growth in obesity care sales, including the successful launch of the Wegovy pill in the US. On the sustainability front, the company advanced its circular economy goals, reducing its relative plastic footprint per patient by 5%, although total Scope 1, 2, and 3 emissions increased by 19% due to manufacturing expansions.
Company: Novo Nordisk AS
Sector: Health Care
Country: Denmark
Year: 2025
Type: AR2
Pages: 137
Novo Nordisk AS
Annual Report
The report highlights Novo Nordisk's performance in 2025, a year of profound transformation marked by a company-wide restructuring that reduced the global workforce by approximately 9,000 positions. Despite these challenges, the company reached 45.6 million patients living with diabetes and obesity, representing a 1% increase from 2024. Financially, sales grew by 6.4% to DKK 309,064 million, driven by a 31% growth in obesity care sales, including the successful launch of the Wegovy pill in the US. On the sustainability front, the company advanced its circular economy goals, reducing its relative plastic footprint per patient by 5%, although total Scope 1, 2, and 3 emissions increased by 19% due to manufacturing expansions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees